Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0001193125-26-036270

Chief Development Officer gave up 14,136 shares (to pay taxes)

  • Chief Development Officer acquired 58,050 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hammond Janet MJ Chief Development Officer 2026-01-31 Option exercise +58,050 141,801 D: show line 1 in the form
Hammond Janet MJ Chief Development Officer 2026-01-31 Shares withheld for taxes −14,136 $4.24 $59,937 127,665 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hammond Janet MJ Chief Development Officer 2026-01-31 Option exercise · Restricted Stock Units −46,800 0 D: show line 3 in the form
Hammond Janet MJ Chief Development Officer 2026-01-31 Option exercise · Restricted Stock Units −11,250 0 D: show line 4 in the form
Hammond Janet MJ Chief Development Officer 2026-01-31 Grant or award · Stock Option (Right to Buy) +177,000 177,000 D: show line 5 in the form
Loading xslF345X05/ownership.xml…